You are here

  • Home
  • Archive
  • Volume 28, Issue 3
  • Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate

Article info

Article menu
Download PDFPDF
Uterine Cancer
Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate

Authors

  1. Address correspondence and reprint requests to Munekage Yamaguchi, MD, PhD, Department of Obstetrics and Gynecology, Faculty of Life Science, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto City, Kumamoto 860-8556, Japan. E-mail: munekage{at}hotmail.co.jp.

Citation

Erdenebaatar C, Yamaguchi M, Saito F, et al
Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate
International Journal of Gynecologic Cancer 2018;28:539-544.

Publication history

  • Received October 27, 2017
  • Accepted December 12, 2017
  • First published March 1, 2018.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.